Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP596135.RAoeX9pCmZwMx8Uq0pfpMMMwzuC8pS9tCMf-C8aEv-xRE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP596135.RAoeX9pCmZwMx8Uq0pfpMMMwzuC8pS9tCMf-C8aEv-xRE130_assertion type Assertion NP596135.RAoeX9pCmZwMx8Uq0pfpMMMwzuC8pS9tCMf-C8aEv-xRE130_head.
- NP596135.RAoeX9pCmZwMx8Uq0pfpMMMwzuC8pS9tCMf-C8aEv-xRE130_assertion wasGeneratedBy ECO_0000203 NP596135.RAoeX9pCmZwMx8Uq0pfpMMMwzuC8pS9tCMf-C8aEv-xRE130_provenance.
- NP596135.RAoeX9pCmZwMx8Uq0pfpMMMwzuC8pS9tCMf-C8aEv-xRE130_assertion wasDerivedFrom befree-2016 NP596135.RAoeX9pCmZwMx8Uq0pfpMMMwzuC8pS9tCMf-C8aEv-xRE130_provenance.
- NP596135.RAoeX9pCmZwMx8Uq0pfpMMMwzuC8pS9tCMf-C8aEv-xRE130_assertion SIO_000772 17326216 NP596135.RAoeX9pCmZwMx8Uq0pfpMMMwzuC8pS9tCMf-C8aEv-xRE130_provenance.
- NP596135.RAoeX9pCmZwMx8Uq0pfpMMMwzuC8pS9tCMf-C8aEv-xRE130_assertion evidence source_evidence_literature NP596135.RAoeX9pCmZwMx8Uq0pfpMMMwzuC8pS9tCMf-C8aEv-xRE130_provenance.
- NP596135.RAoeX9pCmZwMx8Uq0pfpMMMwzuC8pS9tCMf-C8aEv-xRE130_assertion description "[Thus, in patients with HCV-related, histologically proven cirrhosis, achievement of a SVR after IFNalpha therapy was associated with a reduction of liver-related mortality lowering both the risk of complications and HCC development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP596135.RAoeX9pCmZwMx8Uq0pfpMMMwzuC8pS9tCMf-C8aEv-xRE130_provenance.